Not logged in Login 
 Home 
 Managers 
 Funds 
 Charting 
 Ebook 
 Admin   Login  
  Alert me on this fund
  Add fund to active Watchlist
     
Franklin Biotechnology Discovery Fund W  |  USA--Equity--Unclassified
34.6400    +0.2700    (+0.786%)
NAV price (USD) Wed 11 Nov 2026 (change prev close)
  
574.7711    +7.1334    (+1.257%)
NAV price (ZAR) Wed 11 Nov 2026 (change prev close)
 
Snapshot
<i><b>  Performance</b></i><hr/>This gauge shows the decile position of the fund against 22 Rand-denominated Equity-Unclassified funds over the last three years (needle right indicates above average performance)
Performance
<i><b>  Size</b></i><hr/>This gauge shows the size of the fund against all Rand-denominated retail funds (needle right indicates a large fund, needle left a small fund)
Size
<i><b>  Diversification</b></i><hr/>This gauge shows the level of diversification relative to other funds in the same second-tier (equity) category (needle right indicates a well-diversified fund)
Diversification
<i><b>  Risk</b></i><hr/>This gauge shows the fund's level of historical risk relative to other funds in the Equity-Unclassified sectors based on 3-year volatility (needle right indicates lower risk within the sector)
Risk
Fund Performance
  ZAR
  Base
3 Months 6 Months 1 Year 3 Years 5 Years
Trailing Returns
Period    Return %Growth of $1 000
chart
* Not annualised
Key Facts and Fund Objective
Key Facts
Formation Date 16 Oct 2023
Fund Size ($) 1 820 000 000
Latest Price 34.64
PlexCrowns (Senior)
PlexCrowns (Junior)
Total Expense Ratio (30/09) 0.99%
Minimum Investment-
TTM Distribution Yield -
Fund Objective
Fund Objective data for this fund is not available.
Asset Classes and Holdings
Asset Classes as at 30 Jun 2026
 SA Equities0.00%  
 Foreign Equities97.53%  
 SA Bonds0.00%  
 Foreign Bonds0.00%  
 SA Property0.00%  
 Foreign Property0.00%  
 SA Cash0.00%  
 Foreign Cash2.47%  
Top Holdings as at 30 Sep 2026
SecurityValue% of Fund
JAZZ PHARMACEUTICALS PUBLIC LIMITED COMPANY 1 731.5m ZAR5.02%
AMGEN INC. 1 631.4m ZAR4.73%
GILEAD SCIENCES, INC. 1 565.9m ZAR4.54%
VERTEX PHARMACEUTICALS INCORPORATED 1 376.2m ZAR3.99%
ARGENX SE 1 338.3m ZAR3.88%
REGENERON PHARMACEUTICALS INC 1 321.0m ZAR3.83%
REVOLUTION MEDICINES INC 1 165.8m ZAR3.38%
Guardant Health, Inc. 1 041.6m ZAR3.02%
ASTRAZENECA PLC 1 024.4m ZAR2.97%
BridgeBio Pharma, Inc. 872.6m ZAR2.53%
Totals 13 068.8m ZAR37.89%
More Information and Research Tools
Recently viewed
11 Nov34.64+0.27+0.79% 
Watchlists
Portfolios